§7245. Legislative intent It is the intent of the Legislature that the prescription monitoring program established pursuant to this chapter serve as a means to promote the public health and welfare and to detect and prevent substance use disorder. This chapter is not intended to interfere with the legitimate medical use of controlled substances. […]
§7246. Definitions As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. [PL 2003, c. 483, §1 (NEW).] 1. Controlled substance. “Controlled substance” means a controlled substance included in schedules II, III or IV of 21 United States Code, Section 812 or 21 Code of Federal Regulations, […]
§7247. Controlled Substances Prescription Monitoring Program Fund The Controlled Substances Prescription Monitoring Program Fund is established within the department to be used by the commissioner to fund or assist in funding the program. Any balance in the fund does not lapse but is carried forward to be expended for the same purposes in succeeding fiscal […]
§7248. Controlled Substances Prescription Monitoring Program 1. Establishment of monitoring program. Contingent upon the receipt of funds pursuant to section 7247 sufficient to carry out the purposes of this chapter, the Controlled Substances Prescription Monitoring Program is established. No later than January 2, 2004, to implement the program, the department shall establish an electronic system […]
§7249-A. Reporting of methadone treatment with consent (CONTAINS TEXT WITH VARYING EFFECTIVE DATES) (WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2017, c. 243, §5) 1. Consent form; methadone treatment. The department shall develop a consent form to be presented to every patient receiving treatment at any facility that provides methadone for the treatment of […]
§7249-B. Opioid medication distribution monitoring information A manufacturer of an opioid medication that is available in this State and a wholesaler that sells or distributes an opioid medication in this State shall submit to the department, by electronic means or other format specified in a waiver granted by the department, information for this State submitted […]
§7249. Reporting of prescription monitoring information 1. Information required. Except as provided in subsection 1‑A or 1‑B, each dispenser shall submit to the department, by electronic means or other format specified in a waiver granted by the department, specific items of information regarding dispensed controlled substances determined by the department from the following list: […]
§7250. Access to prescription monitoring information and confidentiality (CONTAINS TEXT WITH VARYING EFFECTIVE DATES) 1. Confidentiality. Except as provided in this section, prescription monitoring information submitted to the department is confidential and is not a public record as defined in Title 1, section 402, subsection 3. [PL 2011, c. 657, Pt. AA, §69 (AMD).] […]
§7251. Unlawful acts and penalties 1. Failure to submit information. A dispenser who knowingly fails to submit prescription monitoring information to the department as required by this chapter commits a civil violation for which a fine of $250 per incident, not to exceed $5,000 per calendar year, may be adjudged and is subject to discipline […]
§7252. Rulemaking The department may adopt rules necessary to implement the provisions of this chapter. Rules adopted pursuant to this section are major substantive rules as defined in Title 5, chapter 375, subchapter 2‑A. [PL 2011, c. 657, Pt. AA, §71 (AMD).] SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2011, c. 657, […]
§7253. Prescribers and dispensers required to check prescription monitoring information 1. Prescribers. On or after January 1, 2017, upon initial prescription of a benzodiazepine or an opioid medication to a person and every 90 days for as long as that prescription is renewed, a prescriber shall check prescription monitoring information for records related to that […]
§7254. Exemption from opioid medication limits until January 2017; rulemaking 1. Exemption until January 2017. [PL 2015, c. 488, §9 (NEW); MRSA T. 22 §7254, sub-§1 (RP).] 2. Rulemaking. Notwithstanding section 7252, no later than January 1, 2017, the department shall adopt routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A to […]
